Market Snapshot

BSE Sensex: 85712.37 0.52%
BSE 500: 37394.44 0.39%
BSE 200: 11806.46 0.51%
BSE 100: 27394.16 0.56%
BSE MidCap: 46617.8 0.21%
BSE SmallCap: 51093.23 -0.67%
BSE BANKEX: 67018.67 0.86%
BSE IT: 37364.44 0.64%
Nifty 50: 26186.45 0.59%
Nifty 500: 23835.25 0.40%
Nifty 200: 14541.65 0.52%
Nifty 100: 26696.9 0.53%
Nifty Midcap 100: 60594.6 0.49%
Nifty Small 100: 17507.75 -0.57%
Nifty IT: 38703.65 0.90%
Nifty PSU Bank: 8381.75 1.51%

News:

Hindustan Unilever drops as Kw...
Kaynes Technologies drops as b...
Kaynes Technology India Ltd le...
California Software Company Lt...
Bondada Engineering wins Rs 11...

ERIS Lifesciences Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

Invest

05 Dec 2025 | 03:59 PM

1,552.75

-5.65 (-0.36%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Outperforms Index

7.16%

Return (1Y)

Beaten BSE Healthcare by 7.05%
More Volatile

2.12%

Standard Deviation (1Y)

Higher than BSE Healthcare by 1.16%
Consistent Performer

8/12

Months

beaten BSE Healthcare
AxisDirect View

No View

52 Week High-Low

1,910

1,130

News & Announcements

ERIS Lifesciences board approves acquisition of balance 30% stake in Swiss Parenterals
11 days ago

ERIS Lifesciences board approves acquisition of balance 30% stake in Swiss Parenterals

24 - Nov - 2025 12:00 | 11 days ago

The board of ERIS Lifesciences at its meeting held on 24 November 2025 has approved the acquisition of balance 30% of the total share capital of Swiss Parenterals, a subsidiary of the Company.
Further, the board has approved the issuance of up to 23,06,372 equity shares of the Company on preferential basis to discharge the consideration for acquisition of 30% stake in Swiss Parenterals.
Powered by Capital Market - Live News
ERIS Lifesciences to convene board meeting
16 days ago

ERIS Lifesciences to convene board meeting

19 - Nov - 2025 12:00 | 16 days ago

ERIS Lifesciences will hold a meeting of the Board of Directors of the Company on 24 November 2025.
Powered by Capital Market - Live News
ERIS Lifesciences consolidated net profit rises 31.23% in the September 2025 quarter
21 days ago

ERIS Lifesciences consolidated net profit rises 31.23% in the September 2025 quarter

14 - Nov - 2025 12:00 | 21 days ago

Net profit of ERIS Lifesciences rose 31.23% to Rs 120.19 crore in the quarter ended September 2025 as against Rs 91.59 crore during the previous quarter ended September 2024. Sales rose 6.93% to Rs 790.15 crore in the quarter ended September 2025 as against Rs 738.95 crore during the previous quarter ended September 2024.

Particulars Quarter Ended
Sep. 2025 Sep. 2024 % Var.

Sales 790.15 738.95 7

OPM % 36.48 35.80 -

PBDT 241.75 209.59 15

PBT 172.67 129.11 34

NP 120.19 91.59 31

Powered by Capital Market - Live News
ERIS Lifesciences to table results
25 days ago

ERIS Lifesciences to table results

10 - Nov - 2025 12:00 | 25 days ago

ERIS Lifesciences will hold a meeting of the Board of Directors of the Company on 12 November 2025.
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

FII shareholding in ERIS Lifesciences Ltd has decreased by -14.08% since past 3 Months
MF shareholding in ERIS Lifesciences Ltd has increased by 3.31% since past 3 Months
FII shareholding in ERIS Lifesciences Ltd has decreased by -9.98% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	790.15	738.95	7
OPM %	36.48	35.80	-
PBDT	241.75	209.59	15
PBT	172.67	129.11	34
NP	120.19	91.59	31

General Notifications

My Notifications

Research Notifications

ERIS Lifesciences Ltd Share Price – NSE / BSE Pharmaceuticals, Small Cap

1,552.75 -5.65 (-0.36%)

News & Announcements

Price vs Volume

Stock Trivia

ERIS Lifesciences Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

1,552.75

-5.65 (-0.36%)